New data support long-term safety and efficacy of weekly and monthly subcutaneous buprenorphine depots in patients with opioid use disorder.

Read more

On April 18, 2017 the purchase deed was signed and Sandberg Development is now the owner of the property.

Read more

One year after the reconstruction work started, the new production facilities were completed in March 2017.

Read more

Archives